Skip to main content
Signal8

Zelira Therapeutics Limited (ZLDAF)

Sector: Biotechnology

Industry: Biotechnology

Zelira Therapeutics Limited logo

Zelira Therapeutics Limited

OTC:ZLDAFHealthcare
CLOSED
Mkt Cap$2.69M
EV-
Float12.56M
O/S13.15M
VOL1K sh
$ Vol$227
RVOL3.06×
Inst Own-
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 5, 20260.00890.40000.00890.20451,406
Nov 2, 20260.00890.00890.00890.0089114
Oct 30, 20260.01000.01000.01000.0100200
Oct 26, 20260.20500.20500.20500.2050114
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Zelira Therapeutics Limited is an Australian biopharmaceutical company dedicated to the research, development, and commercialization of cannabinoid-derived therapeutic agents, aimed at treating a variety of medical conditions.

The firm offers its HOPE brand formulations in Pennsylvania and Louisiana, and is actively developing Zenivol, a cannabinoid-based medicine specifically designed for chronic insomnia. Beyond its prescription products, Zelira also markets several over-the-counter (OTC) items, including SprinJene for oral care and RAF FIVE for dermatological applications. A notable OTC offering is ITURA, an advanced topical cream formulated to alleviate multiple symptoms such as numbness, tingling sensations, muscle cramps, reduced sensitivity, and pain frequently associated with Peripheral Artery Disease and diabetes. Zelira Therapeutics has cultivated strategic partnerships with prominent institutions, including Curtin University, the Telethon Kids Institute, the University of Western Australia, St. Vincent's Hospital, and the Children's Hospital of Philadelphia. Incorporated in 2003, the company, which officially changed its name from Zelda Therapeutics Limited in December 2019, maintains its corporate headquarters in Perth, Australia.

Key Metrics
Market Cap$2.69M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 13.15M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryAUAU
IPO Date-
Shares Outstanding13.15M
Authorized Shares
Float12.56M
52-Week Range
Volume
Average Daily Volume459

30d Avg

459

60d Avg

459

90d Avg

459

Earnings
Dividend History
No dividend history available